Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older

Frederik B Thomsen, Mikkel Bandak, Maria F Thomsen, Jakob Lauritsen, Ib J Christensen, Gedske Daugaard

    15 Citations (Scopus)

    Abstract

    Germ-cell cancer (GCC) patients aged ≥40 years have a two-fold higher GCC-specific mortality. It has been hypothesized that reduced treatment intensity combined with increased treatment related toxicity could be the explanation. The objective was to analyze chemotherapy intensity, treatment related toxicity and survival in patients aged ≥40 years treated with standard chemotherapy for GCC compared with a younger control group that received similar treatment during the same period.
    Original languageEnglish
    JournalCancer
    Volume120
    Issue number1
    Pages (from-to)43-51
    Number of pages9
    ISSN0008-543X
    DOIs
    Publication statusPublished - 1 Jan 2014

    Fingerprint

    Dive into the research topics of 'Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older'. Together they form a unique fingerprint.

    Cite this